The EarlyCDT® Lung test detects the presence of autoantibodies generated by the body’s immune system, a natural defense against cancer cells. This aids in the early detection of lung cancer in high-risk patients.
The EarlyCDT® Lung test detects the presence of autoantibodies generated by the body’s immune system, a natural defense against cancer cells. This aids in the early detection of lung cancer in high-risk patients.
The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.
With 10 categories to enter, now’s the time to showcase your achievements.
Deadline date: 9th January 2026
Start your application today.